GBT
Global Blood Therapeutics Inc
Price:  
68.49 
USD
Volume:  
3,279,960.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GBT WACC - Weighted Average Cost of Capital

The WACC of Global Blood Therapeutics Inc (GBT) is 7.5%.

The Cost of Equity of Global Blood Therapeutics Inc (GBT) is 7.75%.
The Cost of Debt of Global Blood Therapeutics Inc (GBT) is 7.00%.

Range Selected
Cost of equity 6.90% - 8.60% 7.75%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.7% - 8.2% 7.5%
WACC

GBT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.67 0.67
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 8.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.13 0.13
Cost of debt 7.00% 7.00%
After-tax WACC 6.7% 8.2%
Selected WACC 7.5%